Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S

被引：0
|
作者：
Osoegawa, A. [1 ]
Hashimoto, T. [1 ]
Takumi, Y. [1 ]
Kobayashi, R. [1 ]
Miyawaki, M. [1 ]
Takeuchi, H. [1 ]
Okamoto, T. [1 ]
Sugio, K. [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Yufu, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Acquired resistance; EGFR-TKI; PTEN;
D O I：
10.1016/j.jtho.2017.09.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02-039
引用
收藏
页码：S2251 / S2251
页数：1
相关论文
共 50 条
  • [1] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    CANCER SCIENCE, 2018, 109 : 1101 - 1101
  • [2] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Atsushi Osoegawa
    Takafumi Hashimoto
    Yohei Takumi
    Miyuki Abe
    Tomonori Yamada
    Ryoji Kobayashi
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    Investigational New Drugs, 2018, 36 : 999 - 1005
  • [3] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Yamada, Tomonori
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
  • [4] Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
    Zhang, P.
    Tu, L.
    Liu, R.
    Xu, X.
    Bao, Z.
    Xu, P.
    Wang, J.
    Li, H.
    Zhou, J.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S403
  • [5] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [6] Management of patients with resistance to EGFR-TKI
    Barlesi, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 : S30 - S35
  • [7] Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
    Uramoto, Hidetaka
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Kuwano, Michihiko
    Ono, Mayumi
    LUNG CANCER, 2011, 73 (03) : 361 - 365
  • [8] Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
    Cheong, Hio Teng
    Xu, Fei
    Choy, Chi Tung
    Hui, Connie Wun Chun
    Mok, Tony Shu Kam
    Wong, Chi Hang
    ONCOLOGY LETTERS, 2018, 15 (01) : 901 - 907
  • [9] SEVERAL RECEPTOR TYROSINE KINASE IS ACTIVATED BUT ORCHESTRATED BY EGFR IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMA CELLS WITH EGFR MUTATION
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Sato, Katsuaki
    Takemoto, Toshiki
    Iwasaki, Takuya
    Minami, Kenji
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S771 - S772
  • [10] Identification of expression profiles and transcription factors during EGFR-TKI acquired resistance in LUAD
    Feng, Lili
    Wang, Cenzhu
    Chen, Jiawen
    Tao, Chenyue
    Zhang, Liuliu
    Zhou, Luojing
    PRECISION MEDICAL SCIENCES, 2024, 13 (04): : 221 - 231
12345